Winst gevend schreef op 17 juli 2023 12:23:
.
17 July 2023
EMA/CHMP/289654/2023
Human Medicines Division / 17 July 2023, 13:00 – 19:30, virtual meeting/room 1C
3.2.4. leniolisib - Orphan - EMEA/H/C/005927
Pharming Technologies B.V.; Treatment of activated phosphoinositide 3-kinase delta syndrome (APDS)
Scope: List of outstanding issues
Action: For adoption
List of Questions adopted on 24.01.2023.